Simbrich Alexandra, Wellmann Ina, Heidrich Jan, Heidinger Oliver, Hense Hans-Werner
Institute of Epidemiology and Social Medicine, University of Münster, Germany.
Epidemiological Cancer Registry North Rhine-Westphalia, Münster, Germany.
Cancer Epidemiol. 2016 Oct;44:44-51. doi: 10.1016/j.canep.2016.07.006. Epub 2016 Jul 25.
Mammography screening programs (MSPs) aim to detect early-stage breast cancers in order to decrease the incidence of advanced-stage breast cancers and to reduce breast cancer mortality. We analyzed the time trends of advanced-stage breast cancer incidence rates in the target population before and after implementation of the MSP in a region of northwestern Germany.
The MSP in the Münster district started in October 2005. A total of 13,874 women with an incident invasive breast cancer (BC) was identified by the population-based epidemiological cancer registry between 2000 and 2013 in the target group 50-69 years. Multiple imputation methods were used to replace missing data on tumor stages (10.4%). The incidence rates for early-stage (UICC I) and advanced-stage (UICC II+) BC were determined, and Poisson regression analyses were performed to assess trends over time.
The incidence rates for UICC I breast cancers increased during the step-up introduction of the MSP and remained elevated thereafter. By contrast, after increasing from 2006 to 2008, the incidence rates of UICC II+ breast cancers decreased to levels below the pre-screening period. Significantly decreasing UICC II+ incidence rates were limited to the age group 55-69 years and reached levels that were significantly lower than incidence rates in the pre-screening period.
The incidence rates of advanced-stage breast cancers decreased in the age groups from 55 years to the upper age limit for screening eligibility, but not in the adjacent age groups. The findings are consistent with MSP lead time effects and seem to indicate that the MSP lowers advanced-stage breast cancer rates in the target population.
乳腺钼靶筛查项目(MSPs)旨在检测早期乳腺癌,以降低晚期乳腺癌的发病率并减少乳腺癌死亡率。我们分析了德国西北部某地区实施MSP前后目标人群中晚期乳腺癌发病率的时间趋势。
明斯特地区的MSP于2005年10月启动。2000年至2013年期间,基于人群的癌症登记处共识别出13874名患有侵袭性乳腺癌(BC)的50至69岁目标组女性。采用多重填补方法替代肿瘤分期的缺失数据(10.4%)。确定了早期(UICC I)和晚期(UICC II+)BC的发病率,并进行泊松回归分析以评估随时间的趋势。
UICC I期乳腺癌的发病率在MSP逐步引入期间有所上升,并在此后保持在较高水平。相比之下UICC II+期乳腺癌的发病率在2006年至2008年上升后,降至筛查前水平以下。UICC II+期发病率的显著下降仅限于55至69岁年龄组,且降至显著低于筛查前时期的发病率水平。
晚期乳腺癌的发病率在55岁至筛查资格上限年龄组有所下降,但相邻年龄组未出现下降。这些发现与MSP的领先时间效应一致,似乎表明MSP降低了目标人群中晚期乳腺癌的发病率